Hims Q2 Beat Fails to Quiet Margin Concerns as Sell Rating Reinforced

What happened

Hims & Hers Health reported strong Q2 2026 revenue growth of 38% but suffered sharp margin compression, with gross margin falling to 64% from 76% a year earlier and a net loss of $86.3 million. Management raised full-year revenue guidance to $3.1–$3.3 billion, yet left the adjusted EBITDA outlook unchanged, signaling that higher costs from the branded GLP-1 transition and international expansion are eroding profitability. A Seeking Alpha analysis rates the stock a Sell, arguing the raised guidance does not fix the underlying margin problem and that the shift to weight-loss drugs and overseas growth complicates the profit story. This bearish view reinforces existing concerns about the sustainability of Hims’ economics after the compounded GLP-1 reset and amid FTC legal pressures. With the stock still trading at approximately 45x EV/EBITDA, the risk–reward remains unfavorable until evidence of stabilizing retention and margins emerges.

Implication

Hims’ Q2 revenue beat was overshadowed by a gross margin decline to 64%, a net loss, and negative free cash flow, confirming that the shift to branded weight-loss drugs is structurally lowering profitability. Even with raised revenue guidance, the adjusted EBITDA outlook remains flat, and the FTC lawsuit adds operational risk. At ~45x EV/EBITDA, the stock prices in a smooth recovery that is far from assured. Investors should wait until the next quarterly data shows stabilization in U.S. weight-loss retention and gross margin recovery before adding exposure. A more attractive entry point exists around $24, where the bear-case scenario factors in further subscriber churn and legal remediation costs.

Thesis delta

The thesis remains firmly bearish: the guidance raise does not offset a 12-point gross margin contraction, and the branded GLP-1 pivot continues to erode profitability. The Seeking Alpha Sell rating echoes our view that the stock’s premium multiple offers no margin of safety until operating trends stabilize.